Fresh Tracks Therapeutics is a clinical-stage pharmaceutical company dedicated to transforming patient lives through the development of innovative prescription therapeutics. With a focus on groundbreaking solutions, Fresh Tracks Therapeutics aims to disrupt existing treatment paradigms in autoimmune, inflammatory, and other debilitating diseases. Their current pipeline consists of new chemical entities that target novel and specific immune system components, offering a fresh approach to treatment.

By moving away from generalized approaches, Fresh Tracks Therapeutics is pioneering science-driven therapies that can effectively address high-impact diseases while minimizing life-impacting side effects. Guided by a set of core values, Fresh Tracks Therapeutics is committed to developing cutting-edge prescription therapeutics that can truly transform the lives of patients. As they continue to make fresh tracks in medicine, the company remains dedicated to delivering innovative solutions and improving patient outcomes